Development of quantitative polymerase chain reaction assays for allelic discrimination of gangliosidoses in cats

American Journal of Veterinary Research

Volumn 68, Issue 3, 2007, Pages 231-235

  Wang, Chi Young J ^a,b   Smith, Bruce F ^a  

^a AUBURN UNIVERSITY   (United States)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ANIMAL CELL; ARTICLE; CAT; CAT DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GANGLIOSIDOSIS; GENE SEQUENCE; GENETIC SCREENING; GENOTYPE; GM1 GANGLIOSIDOSIS; GM2 GANGLIOSIDOSIS; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY;

ALLELES; ANIMALS; CAT DISEASES; CATS; GANGLIOSIDOSES, GM2; GANGLIOSIDOSIS, GM1; POLYMERASE CHAIN REACTION;

FELIDAE; FELIS CATUS;

EID: 33947702640     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.3.231     Document Type: Article

References (18)

1. Barker CG, Blakemore WF, Dell A, et al. GM1 gangliosidosis (type I) in a cat. Biochem J 1986;235:151-158.
2. Baker HJ, Smith BF, Martin DR, et al. Molecular diagnosis of the feline gangliosidosis: a model for elimination of inherited disease in pure breeds. In: August J, ed. Consultations in feline internal medicine. Vol 4. Orlando, Fla: WB Saunders Co, 2001;615-620.
3. Suzuki Y, Sakuraba H, Oshima A. Beta-galactosidase deficiency (beta galactosidosis): GM1 gangliosidosis and Morquio B disease. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill Book Co, 1995;2785-2823.
4. Cox NR, Morrison NE, Sartin JL, et al. Alternations in the growth hormone/insulin-like growth factor I pathways in feline GM1 gangliosidosis. Endocrinology 1999;140:5698-5704.
5. Baker HJ, Lindsey JR, McKhann GM, et al. Neuronal GM1 gangliosidosis in a Siamese cat with beta galactosidase deficiency. Science 1971;174:838-839.
6. Cork LC, Munnell JF, Lorenz MD. The pathology of feline GM2 gangliosidosis. Am J Pathol 1978;90:723-734.
7. De Maria R, Divan S, Bo S, et al. Beta-galactosidase deficiency in a Korat cat: a new form of feline GM1-gangliodosis. Acta Neuropathol 1998;96:307-314.
8. Muldoon LL, Neuwelt EA, Pagel MA, et al. Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). Am J Pathol 1994;144:1109-1118.
9. Neuwelt EA, Johnson WG, Blank NK, et al. Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. J Clin Invest 1985;76:482-490.
10. O'Neil DC, Bartholomew WR, Rattazzi MC. Antigenic homology of feline and human beta-hexosaminidase. Biochim Biophys Acta 1979;580:1-9.
11. Martin DR, Krum BK, Varadarajan GS, et al. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant. Exp Neurol 2004;187:30-37.
12. Skelly BJ, Franklin RJM. Recognition and diagnosis of lysosomal storage disease in the cat and dog. J Vet Intern Med 2002;16: 133-141.
13. Fujii K, Matsubara Y, Akanuma J, et al. Mutation detection by Taq-Man-allele specific amplification: application to molecular diagnosis of glycogen storage disease type Ia and medium-chain acyl-CoA dehydrogenase deficiency. Hum Mutat 2000;15:189-196.
14. Iitia A, Hogdall E, Dahlen P, et al. Detection of mutation DF508 in the cystic fibrosis gene using allelic-specific PCR primers and time-resolved fluorometry. PCR Methods Appl 1992;2:157-162.
15. Higuchi R, Dollinger G, Walsh PS, et al. Simultaneous amplification of specific DNA sequences. Biotechnology (N Y) 1992;10:413-417.
16. Higuchi R, Fockler C, Dolliner G, et al. Kinetic PCR: real time monitoring of DNA amplification. Biotechnology (N Y) 1993;11:1026-1030.
17. Ballerini S, Bellincampi L, Bernardini S, et al. Apolipoprotein E genotyping: a comparative study between restriction endonuclease mapping and allelic discrimination with the lightcycler. Clin Chim Acta 2002;317:71-76.
18. Belak S, Thoren P. Molecular diagnosis of animal disease: some ex-